Physician profile
Mohammed Mohye Eldin Omar
NPI 1093243503
$4,388.99
in general payments reported to CMS, 2019-2025
16 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $2,131 · 2023: $1,128 · 2024: $473 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951 · Education: $32.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.42 |
| Education | $32.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,219.39 | 2022 | |
| Boston Scientific Corporation | $1,033.71 | 2022-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Nevro Corp. | $395.41 | 2023-2024 | Senza |
| Medtronic, INC. | $332.45 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Painteq LLC | $253.46 | 2023-2024 | Painteq |
| Stryker Corporation | $208.27 | 2022 | |
| Spinal Simplicity, LLC | $198.13 | 2022 | |
| Vertos Medical, INC. | $133.30 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.87 | 2022 | |
| Spr Therapeutics, INC | $84.46 | 2021-2022 | |
| Abbvie INC. | $47.14 | 2023 | |
| Globus Medical, INC. | $38.96 | 2025 | Senza |
| Amgen INC. | $26.00 | 2022 | |
| Smith+Nephew, INC. | $19.53 | 2025 | Footprint |
| Collegium Pharmaceutical, INC. | $17.23 | 2023 | Belbuca |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $14.77 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Omar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.